ODD
ODDITY Tech Ltd.
Latest News for ODD
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD – Research Report) and Resmed (RMD – R......
In a report released today, Cory Carpenter from J.P. Morgan maintained a Buy rating on ODDITY Tech Ltd. Class A, with a price target of $59.00. Acc......
Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest profits drives continued......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioAge Labs, Inc. (BIOA – Research Report) and Ins......
In a report released today, Patrick Wood from Morgan Stanley maintained a Buy rating on Insulet, with a price target of $370.00. Wood covers the He......
In a report released today, Richard Newitter from Truist Financial reiterated a Buy rating on Insulet, with a price target of $412.00. Newitter cov......
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Insulet yesterday and set a price target of $380.00. The company’s shares closed......
ODDITY Tech Ltd. Class A ( ($ODD) ) has released its Q3 earnings. Here is a breakdown of the information ODDITY Tech Ltd. Class A presented to its ......
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on ODDITY Tech Ltd. Class A (ODD – Research Report) and......
An update from ODDITY Tech Ltd. Class A ( ($ODD) ) is now available. On November 19, 2025, ODDITY Tech Ltd. announced its financial results for the......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 11 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ODD | $43.82 | -1.4% | 684.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |